SynthesisBMC pulmonary medicine2026
Neutrophil-to-lymphocyte ratio for predicting disease severity and outcomes in children with Mycoplasma pneumoniae pneumonia: a systematic review and meta-analysis.
Synthesis in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Neutrophil-to-lymphocyte ratio mediates pulmonary consolidation through oxidative stress in children withAnnals of medicine · 2026Article
- Early Clinical and Inflammatory Predictors of Supplemental Oxygen Requirement in Children Hospitalized with Acute Lower Respiratory Infection: A Multivariable Analysis.Microorganisms · 2026Article
- Association between normalizedTranslational pediatrics · 2026Article
- Prediction of In-Hospital Respiratory Support Among Children Aged 2-59 Months Hospitalized with Pneumonia in Southern Vietnam: A Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Admission-time immunologic patterns in hospitalized children withFrontiers in pediatrics · 2026Article
- Clinical value of neutrophil-to-lymphocyte ratio and D-dimer in predicting the efficacy of minocycline for pediatric Mycoplasma pneumoniae pneumonia.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo systematically evaluate the diagnostic and prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in children with Mycoplasma pneumoniae pneumonia (MPP).
methodsA comprehensive search of PubMed, Embase, Web of Science, Cochrane Library, Scopus, Wanfang, and CNKI was performed from inception to November 1, 2025. Observational studies assessing the association between NLR and the occurrence of MPP, refractory MPP (RMPP), severe MPP (SMPP), or poor prognosis in children were included. Two reviewers independently screened the literature, extracted data, and assessed the risk of bias. Random-effects models were applied to pool odds ratios (OR) and standardized mean differences (SMD) with 95% confidence intervals (CI). Meta-regression analyses were conducted to explore potential sources of heterogeneity.
resultsTwenty-six studies involving 7,013 participants were included. Elevated NLR was significantly associated with the occurrence of MPP (6 studies, SMD = 1.91, 95% CI: 1.07–2.76), RMPP (5 studies, OR = 2.15, 95% CI: 1.44–3.21; 7 studies, SMD = 0.82, 95% CI: 0.64–1.00), SMPP (4 studies, OR = 1.41, 95% CI: 1.27–1.56; 9 studies, SMD = 1.36, 95% CI: 0.79–1.93), and poor prognosis (8 studies, OR = 1.55, 95% CI: 1.30–1.84; 10 studies, SMD = 1.13, 95% CI: 0.74–1.53). Meta-regression indicated that geographic region accounted for most heterogeneity in MPP analyses (R²= 70.0%), while sample size contributed substantially to heterogeneity in SMPP (R²= 51.2%) and adverse outcome analyses (R²= 60.5%). Sensitivity analyses confirmed the robustness of the findings.
conclusionsAs an adjunct to clinical assessment and etiological testing, NLR shows potential as a supportive biomarker for the early risk stratification and prognosis monitoring of pediatric MPP. Substantial heterogeneity was observed across continuous analyses, and most included studies originated from East Asia, which may limit generalizability. Its simplicity and low cost suggest possible clinical utility, particularly in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.